中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.

文献类型:期刊论文

作者Jiang, Feng; Chen, Xiaozhong; Liu, Tongxin; Qin, WeiFeng; Huang, Shuang; Cao, Caineng; Jin, Ting; Jin, Qifeng
刊名JOURNAL OF CLINICAL ONCOLOGY
出版日期2022-06-01
卷号40
ISSN号0732-183X
WOS研究方向Oncology
语种英语
出版者LIPPINCOTT WILLIAMS & WILKINS
WOS记录号WOS:000863680303641
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129925]  
专题中国科学院合肥物质科学研究院
作者单位Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Jiang, Feng,Chen, Xiaozhong,Liu, Tongxin,et al. Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA Jiang, Feng.,Chen, Xiaozhong.,Liu, Tongxin.,Qin, WeiFeng.,Huang, Shuang.,...&Jin, Qifeng.(2022).Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study..JOURNAL OF CLINICAL ONCOLOGY,40.
MLA Jiang, Feng,et al."Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.".JOURNAL OF CLINICAL ONCOLOGY 40(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。